angiotensin ii has been researched along with Kidney Failure in 42 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 6 (14.29) | 18.2507 |
2000's | 23 (54.76) | 29.6817 |
2010's | 13 (30.95) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fujigaki, Y; Ishizawa, K; Li, J; Lifton, RP; Shibata, S; Tamura, Y; Uchida, S; Wang, Q; Yamazaki, O | 1 |
Bo, L; Chen, J; Chen, N; Li, D; Li, S; Liu, R; Mao, C; Xia, S; Xu, Z; Zhang, L | 1 |
Chatsudthipong, V; Kongrat, S; Muanprasat, C; Srisawat, U | 1 |
Bürgelová, M; Červenka, L; Hammock, BD; Husková, Z; Hwang, SH; Imig, JD; Melenovský, V; Sadowski, J; Škaroupková, P; Sporková, A | 1 |
Alarcón, B; Bustelo, XR; Fabbiano, S; García-Macías, C; López-Novoa, JM; Martín, P; Matesanz-Marín, A; Menacho-Márquez, M; Montero, MJ; Pericacho, M; Robles-Valero, J; Sevilla, MA | 1 |
Gao, HQ; Liang, Y; Qiu, J; Wang, J; Wang, QZ; Zhang, J | 1 |
Aroor, A; Duta, C; Meuth, A; Nistala, R; Sowers, JR; Whaley-Connell, A; Zuberek, M | 1 |
Chiu, AT; Smith, RD; Timmermans, PB; Wong, PC | 1 |
Cho, HJ; Choi, JB; Kim, YS; Lee, BC | 1 |
Agharazii, M; Bélanger, S; Larivière, R; Lebel, M; Lemieux, P; Therrien, F | 1 |
Burke, SL; Carroll, JF; Eppel, GA; Evans, RG; Head, GA; Michaels, S; Nematbakhsh, M; O'Connor, PM | 1 |
Carpini, SD; Casamassima, N; Gatti, G; Hamlyn, JM; Manunta, P; Messaggio, E; Zagato, L | 1 |
Kim, HJ; Rodríguez-Iturbe, B; Sato, T; Vaziri, ND | 1 |
Bader, M; Beyermann, M; Günthner, T; Jankowski, J; Jankowski, V; Krause, E; Kretschmer, A; Lautner, R; Pinheiro, SV; Sampaio, WO; Santos, RA; Tölle, M; van der Giet, M; Welker, P; Zidek, W | 1 |
Kasai, M; Miyazaki, T; Suzuki, H; Takenaka, T; Yanagisawa, H | 1 |
Jo, CH; Simoni, J; Wesson, DE | 1 |
Honeck, H; Kaergel, E; Luft, FC; Mullally, A; Muller, DN; Schunck, WH; Shagdarsuren, E; Theuer, J | 1 |
Ebihara, A; Hirata, Y; Iimuro, S; Iwata, H; Nagai, R; Niu, P; Shindo, T; Suematsu, Y; Takeda, N; Zhang, Y | 1 |
Alcázar, R; Egido, J; Ruiz-Ortega, M | 1 |
Marshall, SM | 1 |
Herrera-Acosta, J; Johnson, RJ; Long, DA; Price, KL | 1 |
Habicht, A; Watschinger, B | 1 |
Adamczak, M; Gross, ML; Ritz, E | 1 |
Alexander, D; Chinnaiyan, KM; McCullough, PA | 1 |
Hishida, A; Ikegaya, N | 1 |
Garaliene, V | 1 |
Cheunsuchon, B; Parichatikanond, P; Sanpakit, K; Supavekin, S | 1 |
Aihara, K; Akaike, M; Azuma, H; Ikeda, Y; Ise, T; Ishikawa, K; Iwase, T; Matsumoto, T; Sumitomo, Y; Yagi, S; Yoshida, S | 1 |
Andreini, B; Bertelli, A; Bertelli, AA; Bianchi, AM; De Pietro, S; Giovannini, L; Migliori, M; Palla, R; Panichi, V; Parrini, M | 1 |
Abdi, A; Johns, EJ | 1 |
Textor, SC | 1 |
Mann, JF | 1 |
Fierro, G; Ram, S; Venkata, C | 1 |
Meyer, TW; Olson, JL; Sorooshian, M | 1 |
McInnes, GT | 1 |
Böhm, M; Schwaab, B | 1 |
Bautista, R; Escalante, B; Hernández, J; Oyekan, A; Sánchez, A | 1 |
Hostetter, TH; Ibrahim, HN; Juknevicius, I; Rosenberg, ME | 1 |
Bonnet, F; Cao, Z; Cox, A | 1 |
Astudillo, H; Escalante, B; Hernández, J | 1 |
Easthope, SE; Jarvis, B | 1 |
Akimoto, K; Kangawa, K; Kobayashi, N; Matsuoka, H; Mori, Y; Nishikimi, T; Tadokoro, K; Wang, X; Yoshihara, F | 1 |
13 review(s) available for angiotensin ii and Kidney Failure
Article | Year |
---|---|
The preclinical basis of the therapeutic evaluation of losartan.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Disease Models, Animal; Humans; Hypertension; Losartan; Rats; Rats, Inbred SHR; Renal Insufficiency; Renin-Angiotensin System | 1995 |
Endogenous ouabain in renal Na(+) handling and related diseases.
Topics: Adrenal Glands; Angiotensin II; Animals; Cell Proliferation; Diuretics; Drosophila; Epinephrine; Heart Failure; Homeostasis; Humans; Hypertension; Kidney; Myocytes, Cardiac; Myocytes, Smooth Muscle; Ouabain; Renal Insufficiency; Sodium; Sodium-Calcium Exchanger; Sodium-Potassium-Exchanging ATPase; Vasoconstriction | 2010 |
[Angiotensin II : a key peptide in vascular and renal failure].
Topics: Angiotensin II; Animals; Clinical Trials as Topic; Humans; Mice; Rats; Renal Insufficiency; Vascular Diseases | 2003 |
Renal failure and ACE inhibition: how much is too much?
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Dose-Response Relationship, Drug; Glomerular Filtration Rate; Humans; Kidney Concentrating Ability; Kidney Function Tests; Renal Insufficiency; Renin-Angiotensin System | 2005 |
Role of angiotensin II in the evolution of diastolic heart failure.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Heart Failure; Humans; Hypertension; Hypertrophy, Left Ventricular; Mineralocorticoid Receptor Antagonists; Prognosis; Renal Insufficiency; Renin-Angiotensin System; Treatment Outcome | 2005 |
[Molecular mechanisms of progression in renal failure].
Topics: Ammonia; Angiotensin II; Animals; Disease Progression; Glomerular Filtration Rate; Humans; Kidney Glomerulus; Kidney Tubules; Nephrons; Oxidative Stress; Proteinuria; Renal Insufficiency | 2006 |
[The main determinants of endothelial dysfunction].
Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Arteriosclerosis; Biological Availability; Diabetes Mellitus; Endothelium, Vascular; Free Radicals; Heart Failure; Homocysteine; Humans; Hypertension; Hypolipidemic Agents; Middle Aged; Models, Biological; Muscle, Smooth, Vascular; Nitric Oxide; Oxidative Stress; Potassium Channels; Reactive Oxygen Species; Renal Insufficiency; Risk Factors; Vasodilation | 2006 |
Renal failure related to angiotensin-converting enzyme inhibitors.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Glomerular Filtration Rate; Humans; Kidney; Potassium; Renal Insufficiency; Risk Factors | 1997 |
Valsartan and the kidney: present and future.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Humans; Hypertension; Kidney Diseases; Renal Insufficiency; Tetrazoles; Valine; Valsartan | 1999 |
The benefits of angiotensin II receptor blockers in patients with renal insufficiency or failure.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Disease Models, Animal; Humans; Hypertension; Losartan; Rats; Renal Insufficiency; Renin-Angiotensin System; Treatment Outcome | 1998 |
Clinical potential: angiotensin converting enzyme inhibitor or angiotensin II antagonist?
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Humans; Hypertension; Myocardial Infarction; Renal Insufficiency; Renin-Angiotensin System | 2001 |
Aldosterone in progressive renal disease.
Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Humans; Hyperaldosteronism; Kidney Diseases; Rats; Rats, Inbred WF; Renal Insufficiency; Renin-Angiotensin System | 2001 |
Candesartan cilexetil: an update of its use in essential hypertension.
Topics: Adsorption; Age Factors; Aged; Angiotensin II; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Black People; Diabetes Mellitus, Type 2; Drug Interactions; Humans; Hypertension; Hypertrophy, Left Ventricular; Kidney; Renal Insufficiency; Tetrazoles; Treatment Outcome | 2002 |
1 trial(s) available for angiotensin ii and Kidney Failure
Article | Year |
---|---|
Acute effects of calcitonin gene related peptide on renal haemodynamics and renin and angiotensin II secretion in patients with renal disease.
Topics: Adult; Aged; Angiotensin II; Calcitonin Gene-Related Peptide; Female; Hemodynamics; Humans; Hypertension; Infusions, Intravenous; Male; Middle Aged; Renal Circulation; Renal Insufficiency; Renin; Time Factors | 1995 |
28 other study(ies) available for angiotensin ii and Kidney Failure
Article | Year |
---|---|
Calcineurin dephosphorylates Kelch-like 3, reversing phosphorylation by angiotensin II and regulating renal electrolyte handling.
Topics: Adaptor Proteins, Signal Transducing; Angiotensin II; Animals; Calcineurin; Calcineurin Inhibitors; Carrier Proteins; Cullin Proteins; Gene Expression Regulation; Germ-Line Mutation; Humans; Hyperkalemia; Hypertension; Kidney; Kidney Tubules, Distal; Mice; Microfilament Proteins; Multiprotein Complexes; Phosphorylation; Protein Serine-Threonine Kinases; Renal Insufficiency; T-Lymphocytes; Tacrolimus; Ubiquitination | 2019 |
High-salt diets during pregnancy affected fetal and offspring renal renin-angiotensin system.
Topics: Angiotensin II; Angiotensinogen; Animals; Electrolytes; Female; Fetal Blood; Gene Expression Regulation, Developmental; Kidney; Male; Maternal Nutritional Physiological Phenomena; Peptidyl-Dipeptidase A; Pregnancy; Receptors, Angiotensin; Renal Insufficiency; Renin-Angiotensin System; RNA, Messenger; Sheep, Domestic; Sodium Chloride, Dietary; Urine; Vasopressins | 2013 |
Losartan and Sodium Nitroprusside Effectively Protect against Renal Impairments after Ischemia and Reperfusion in Rats.
Topics: Adenosine Triphosphatases; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Arginine; Captopril; Ischemia; Kidney; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Donors; Nitroprusside; Peptides, Cyclic; Rats, Wistar; Renal Insufficiency; Reperfusion; Reperfusion Injury | 2015 |
Inhibition of soluble epoxide hydrolase does not improve the course of congestive heart failure and the development of renal dysfunction in rats with volume overload induced by aorto-caval fistula.
Topics: 8,11,14-Eicosatrienoic Acid; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzoates; Disease Models, Animal; Drug Evaluation, Preclinical; Epoxide Hydrolases; Epoxy Compounds; Heart Failure; Kidney; Male; Myocardium; Peptide Fragments; Random Allocation; Rats; Renal Insufficiency; Renin-Angiotensin System; Ultrasonography; Urea | 2015 |
Immunosuppression-Independent Role of Regulatory T Cells against Hypertension-Driven Renal Dysfunctions.
Topics: Angiotensin II; Animals; Antigens, CD; Apoptosis; Apyrase; Cells, Cultured; Fibrosis; Hypertension; Immune Tolerance; Kidney; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Mice, SCID; Neutrophils; Proto-Oncogene Proteins c-vav; Renal Insufficiency; T-Lymphocytes, Helper-Inducer; T-Lymphocytes, Regulatory | 2015 |
Cofilin1 is involved in hypertension-induced renal damage via the regulation of NF-κB in renal tubular epithelial cells.
Topics: Angiotensin II; Animals; Antioxidants; Chemokine CCL2; Cofilin 1; Creatinine; Cytoskeleton; Epithelial Cells; Gene Expression Regulation; Grape Seed Extract; Humans; Hypertension; Inflammation; Interleukin-1beta; Kidney Tubules; Male; NF-kappa B p50 Subunit; Nitrogen; Proanthocyanidins; Rats; Rats, Inbred SHR; Renal Insufficiency; RNA, Small Interfering; Urea | 2015 |
Angiotensin II Stimulation of DPP4 Activity Regulates Megalin in the Proximal Tubules.
Topics: Angiotensin II; Animals; Cell Line; Dipeptidyl Peptidase 4; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation; Kidney Tubules, Proximal; Low Density Lipoprotein Receptor-Related Protein-2; Male; MAP Kinase Signaling System; Mice; Mice, Obese; Obesity; Renal Insufficiency | 2016 |
Rehmannia glutinosa ameliorates the progressive renal failure induced by 5/6 nephrectomy.
Topics: Albumins; Angiotensin I; Angiotensin II; Animals; Blood Urea Nitrogen; Collagen Type IV; Creatinine; Kidney; Lipids; Male; Nephrectomy; Plant Extracts; Protective Agents; Rats; Rats, Sprague-Dawley; Rehmannia; Renal Insufficiency; RNA, Messenger; Transforming Growth Factor beta1 | 2009 |
Protective effects of angiotensin AT1 receptor blockade in malignant hypertension in the rat.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Atrasentan; Blood Pressure; Endothelin-1; Hydralazine; Hypertension, Malignant; Losartan; Male; Necrosis; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Renal Insufficiency | 2009 |
Multiple mechanisms act to maintain kidney oxygenation during renal ischemia in anesthetized rabbits.
Topics: Acetylcholine; Angiotensin II; Animals; Blood Pressure; Carbon Dioxide; Electric Stimulation; Ischemia; Kidney; Male; Models, Animal; Oxygen; Oxygen Consumption; Rabbits; Renal Insufficiency; Unconsciousness; Vasoconstrictor Agents; Vasodilator Agents | 2010 |
Role of intrarenal angiotensin system activation, oxidative stress, inflammation, and impaired nuclear factor-erythroid-2-related factor 2 activity in the progression of focal glomerulosclerosis.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Disease Progression; Glomerulosclerosis, Focal Segmental; Hypertension; Imidazoles; Kidney; Kidney Diseases; Male; NF-E2 Transcription Factor; NF-kappa B; Oxidative Stress; Proteinuria; Random Allocation; Rats; Rats, Sprague-Dawley; Renal Insufficiency; Tetrazoles; Thiobarbituric Acid Reactive Substances | 2011 |
Angioprotectin: an angiotensin II-like peptide causing vasodilatory effects.
Topics: Aged; Angiotensin II; Animals; Aorta; CHO Cells; Cricetinae; Cricetulus; Female; Humans; Male; Mice; Middle Aged; Rats; Renal Insufficiency; Vasodilation | 2011 |
Excessive zinc intake increases systemic blood pressure and reduces renal blood flow via kidney angiotensin II in rats.
Topics: Angiotensin II; Animals; Arterial Pressure; Carbonates; Down-Regulation; Glomerular Filtration Rate; Hypertension; Inulin; Kidney; Male; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Renal Circulation; Renal Insufficiency; Renin-Angiotensin System; Up-Regulation; Zinc; Zinc Compounds | 2012 |
Angiotensin II receptors mediate increased distal nephron acidification caused by acid retention.
Topics: Acid-Base Equilibrium; Acidosis, Renal Tubular; Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Endothelin Receptor Antagonists; Endothelins; Female; Glomerular Filtration Rate; Kidney Tubules, Distal; Male; Microdialysis; Mineralocorticoid Receptor Antagonists; Nephrectomy; Protons; Rats; Rats, Wistar; Receptor, Angiotensin, Type 2; Receptors, Endothelin; Receptors, Mineralocorticoid; Renal Insufficiency | 2012 |
P450-dependent arachidonic acid metabolism and angiotensin II-induced renal damage.
Topics: Angiotensin II; Angiotensinogen; Animals; Animals, Genetically Modified; Arachidonic Acid; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 2; Hypertension, Renal; Kidney; Kinetics; Oxygenases; Rats; Rats, Sprague-Dawley; Renal Insufficiency; Renin; Renin-Angiotensin System; Steroid 16-alpha-Hydroxylase; Steroid Hydroxylases | 2002 |
Accelerated cardiac hypertrophy and renal damage induced by angiotensin II in adrenomedullin knockout mice.
Topics: Adrenomedullin; Angiotensin II; Animals; Cardiomegaly; Male; Mice; Mice, Knockout; Peptides; Renal Insufficiency; Time Factors; Vasoconstrictor Agents; Vasodilator Agents | 2003 |
Inhibition of the renin-angiotensin system: added value in reducing cardiovascular and renal risk?
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Nephropathies; Humans; Renal Insufficiency; Renin-Angiotensin System; Risk Factors | 2004 |
How does angiotensin II cause renal injury?
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Disease Models, Animal; Disease Progression; Humans; Hypertension; Hypertension, Renal; Kidney Diseases; Kidney Glomerulus; Models, Biological; Peptidyl-Dipeptidase A; Rats; Renal Circulation; Renal Insufficiency; Renin-Angiotensin System; Vasoconstriction | 2004 |
[Renal sequelae of sympathetic hyperactivity].
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Clonidine; Humans; Hypertension; Hypertension, Renal; Hypertension, Renovascular; Hypothalamus; Imidazoline Receptors; Kidney; Norepinephrine; Receptors, Drug; Renal Insufficiency; Renin; Renin-Angiotensin System; Sympathetic Nervous System; Treatment Outcome | 2004 |
A 5-year-old girl with impaired renal function after autologous bone marrow transplantation.
Topics: Angiotensin II; Biopsy; Bone Marrow Transplantation; Child, Preschool; Disease Progression; Female; Humans; Kidney Glomerulus; Renal Insufficiency; Transplantation, Autologous | 2006 |
Pitavastatin, an HMG-CoA reductase inhibitor, exerts eNOS-independent protective actions against angiotensin II induced cardiovascular remodeling and renal insufficiency.
Topics: Angiotensin II; Animals; Cardiotonic Agents; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertrophy, Left Ventricular; Mice; Mice, Inbred C57BL; Mice, Knockout; Nitric Oxide Synthase Type III; Oxidative Stress; Quinolines; Renal Insufficiency; Signal Transduction; Smad2 Protein; Smad3 Protein; Transforming Growth Factor beta; Ventricular Remodeling | 2008 |
Importance of the renin-angiotensin system in the generation of kidney failure in renovascular hypertension.
Topics: Angiotensin II; Animals; Blood Pressure; Captopril; Hypertension, Renovascular; Male; Rats; Rats, Wistar; Renal Insufficiency; Renin-Angiotensin System; Sodium, Dietary | 1996 |
Effect of angiotensin II blockade on renal injury in mineralocorticoid-salt hypertension.
Topics: Administration, Oral; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Disease Models, Animal; Enalapril; Hypertension, Renal; Kidney; Kidney Function Tests; Losartan; Male; Nephrectomy; Proteinuria; Rats; Rats, Wistar; Renal Insufficiency; Sodium Chloride | 2000 |
[ACE inhibitors for therapy of cardiac and kidney insufficiency].
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Constriction, Pathologic; Contraindications; Creatinine; Heart Failure; Humans; Renal Insufficiency | 2001 |
Angiotensin II type AT(2) receptor mRNA expression and renal vasodilatation are increased in renal failure.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 5,8,11,14-Eicosatetraynoic Acid; Angiotensin II; Animals; Antihypertensive Agents; Arachidonic Acid; Clotrimazole; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Gene Expression Regulation; Imidazoles; In Vitro Techniques; Indomethacin; Kidney; Losartan; Male; NG-Nitroarginine Methyl Ester; Oligopeptides; Pyridines; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renal Insufficiency; RNA, Messenger; Vasodilation | 2001 |
Increased osteopontin expression following renal ablation is attenuated by angiotensin type 1 receptor antagonism.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Blood Pressure; Cell Division; Immunohistochemistry; In Situ Hybridization; Irbesartan; Kidney; Leukocytes, Mononuclear; Macrophages; Male; Nephrectomy; Osteopontin; Proliferating Cell Nuclear Antigen; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Renal Insufficiency; RNA, Messenger; Sialoglycoproteins; Tetrazoles; Transcriptional Activation | 2002 |
Angiotensin II stimulates cyclooxygenase-2 mRNA expression in renal tissue from rats with kidney failure.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Cyclooxygenase 2; Gene Expression Regulation, Enzymologic; Immunohistochemistry; Isoenzymes; Kidney; Kidney Function Tests; Male; Nephrectomy; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar; Renal Insufficiency; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stimulation, Chemical | 2002 |
Renoprotective effect of chronic adrenomedullin infusion in Dahl salt-sensitive rats.
Topics: Adrenomedullin; Angiotensin II; Animals; Creatinine; Drug Implants; Glomerulonephritis; Hormones; Hypertension; Kidney; Male; Peptides; Proteinuria; Rats; Rats, Inbred Dahl; Renal Insufficiency; Renin-Angiotensin System; RNA, Messenger; Sodium Chloride; Time Factors; Transforming Growth Factor beta | 2002 |